Jounce Therapeutics
Jounce Therapeutics (JNCE) is a clinical-stage immunotherapy company developing therapies enabling the immune system to attack tumors and provide long-lasting benefits to patients through a biomarker-driven approach. Jounce has ongoing multiple development stage programs while simultaneously advancing additional early-stage assets from its robust discovery engine based on its Translational Science.
Jounce Therapeutics Lead Products
-
This content is for paid subscribers.Trick or Trade September 14, 2021
